CCG 2979

CAS No. 328070-87-7

CCG 2979( CCG2979 )

Catalog No. M14070 CAS No. 328070-87-7

CCG 2979 is a small molecule inhibitor of gene expression of streptokinase (SK), a critical group A streptococcal (GAS) virulence factor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CCG 2979
  • Note
    Research use only, not for human use.
  • Brief Description
    CCG 2979 is a small molecule inhibitor of gene expression of streptokinase (SK), a critical group A streptococcal (GAS) virulence factor.
  • Description
    CCG 2979 is a small molecule inhibitor of gene expression of streptokinase (SK), a critical group A streptococcal (GAS) virulence factor; inhibits expression of SK by 60% at 50 uM based on activity assay, also inhibits the production of active SK protein; enhances granulocyte phagocytosis and killing of GAS in an in vitro assay, also protecteds mice from GAS-induced mortality in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CCG2979
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    328070-87-7
  • Formula Weight
    394.577
  • Molecular Formula
    C24H30N2OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCSC1=NC2=C(C(=O)N1CC=C)C3(CCCCC3)CC4=CC=CC=C42
  • Chemical Name
    2-butylsulfanyl-3-prop-2-enylspiro[6H-benzo[h]quinazoline-5,1'-cyclohexane]-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sun H, et al. Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3469-74.
molnova catalog
related products
  • Cephapirin Sodium

    Cefapirin sodium is the sodium salt of Cephapirin an antimicrobial agent.

  • PBP 10

    Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.

  • NOSO-502

    NOSO-502 (NOSO502) is a novel inhibitor of bacterial translation.